Return to homepagePandemic Pact

No title provided

Grant number: 335681

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $235,996.46

  • Funder

    Academy of Finland

  • Principal Investigator

    Ari Laaksonen

  • Research Location

    Finland

  • Lead Research Institution

    Finnish Meteorological Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Biological properties and transmission modes of the SARS-CoV-2 are currently not fully understood. We study the infectivity and concentration of viruses in aerosol droplets that are generated during coughing, talking or exhaling. We aim to define how infectious viruses are transmitted in aerosols and how significant aerosol transmission is in spreading of the COVID-19 disease.

7 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

High-volume evacuation mitigates viral aerosol spread in dental procedures.

Safe use of PHI6 IN the experimental studies.

Combining Phi6 as a surrogate virus and computational large-eddy simulations to study airborne transmission of SARS-CoV-2 in a restaurant.

Aerosol concentrations and size distributions during clinical dental procedures.

Aerosol generation during general anesthesia is comparable to coughing: An observational clinical study.

Microdebrider is less aerosol-generating than CO2 laser and cold instruments in microlaryngoscopy.

High-resolution large-eddy simulation of indoor turbulence and its effect on airborne transmission of respiratory pathogens-Model validation and infection probability analysis.